Evidence map›Paper›PMID 37445196›Full record

ArticleMaterials (Basel, Switzerland)2023

Physical, Mechanical, and Microstructure Characteristics of Ultra-High-Performance Concrete Containing Lightweight Aggregates.

Aref A Abadel

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Aref A AbadelDepartment of Civil Engineering, College of Engineering, King Saud University, Riyadh 11421, Saudi Arabia.ORCID 0000-0002-8498-1402

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explores and enhances the resistance of an ultra-high-performance concrete (UHPC) to explosive spalling under elevated temperatures. This study investigates the impact of lightweight aggregates (LWAs) on the mechanical and microstructural properties of the UHPC. Various UHPC specimens were created by replacing silica sand with LWAs in percentages ranging from 0% to 30%. The evaluation of these specimens involved assessing their compressive and flexural strengths, density, mass loss, shrinkage, porosity, and microstructural characteristics using scanning electron microscopy (SEM). This study provides valuable insights by analyzing the influence of lightweight aggregates on the strength, durability, and microstructure of UHPC. The results reveal that incorporating LWAs in the UHPC improved its flowability while decreasing its density, as the percentage of LWAs increased from 5% to 30%. Including 30% LWA resulted in a mass loss of 4.8% at 300 °C, which reduced the compressive and flexural strengths across all curing durations. However, the UHPC samples subjected to higher temperatures displayed higher strength than those exposed to ambient conditions. The microstructure analysis demonstrated that the UHPC specimens with 30% LWA exhibited increased density due to continuous hydration from the water in the lightweight aggregate. The pore size distribution graph indicated that incorporating more of the LWA increased porosity, although the returns diminished beyond a certain point. Overall, these findings offer valuable insights into the influence of lightweight aggregates on the physical and strength characteristics of UHPC. This research holds significant implications for developing high-performance, lightweight concrete materials.

Indexed as

durabilitylightweight aggregatesrheologySEM analysisthermal analysis

Identifiers

PMID37445196
PMCPMC10343911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.